Rigel(RIGL) - 2023 Q3 - Earnings Call Presentation
Rigel(RIGL)2023-11-07 21:47Please visit www.TAVALISSE.com for Full Prescribing Information. Please visit www.REZLIDHIA.com for Full Prescribing Information, including Boxed WARNING. Ray Furey, J.D. Dean Schorno Commercial Execution Development & Expansion • Evaluating additional olutasidenib and fostamatinib opportunities Partnered Programs 5 rigel. Select Important Safety Information 6 Please see Important Safety Information on slide 27. Please visit www.TAVALISSE.com for Full Prescribing Information. $24.5M 500 1000 1500 2000 2500 ...